Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Martin Jönsson
Person

Martin Jönsson

Tracked across 1 events · 9 articles · First seen Feb 03, 2026 · Last active Mar 19, 2026

Sentiment
20
Attention
2
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 20
Tech
AlzeCure Pharma ACD856 Preclinical Data
Martin Jönsson, CEO of AlzeCure Pharma, highlighted the promising nature of ACD856 due to its positive clinical and new preclinical results, which open up increased business development opportunities for Alzheimer's disease and depression.
Feb 03, 2026 · 9 articles
Relationships (1)
AlzeCure Pharma CEO ↔ Martin Jönsson Martin Jönsson is the CEO of AlzeCure Pharma.
NEWSDESK
Track Martin Jönsson live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.